Prostratin, a Nonpromoting Phorbol Ester, Inhibits Induction by Phorbol 12-Myristate 13-Acetate of Ornithine Decarboxylase, Edema, and Hyperplasia in CD-I Mouse Skin

Cancer Research

Volumn 51, Issue 19, 1991, Pages 5355-5360

  Szallasi, Zoltan ^a   Blumberg, Peter M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORNITHINE DECARBOXYLASE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROSTRATIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; EDEMA; HYPERPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN;

ANIMAL; BODY WATER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; EDEMA; FEMALE; HYPERPLASIA; MICE; ORNITHINE DECARBOXYLASE; PHORBOL ESTERS; SKIN; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 0026049420     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature (Lond.), 308:693-698, 1984.
2. Nishizuka, Y. Studies and perspectives of protein kinase C. Science (Washington DC), 233:305-312, 1986.
3. Nishizuka, Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature (Lond.), 334:661-665,1988.
4. Blumberg, P. M., Dunn, J. A., Jaken, S., Jeng, A. Y., Leach, K. L., Sharkey, N. A., and Yeh, E. Specific receptors for phorbol ester tumor promoters and their involvement in biological responses. In: T. J. Slaga (ed.), Mechanisms of Tumor Promotion, Vol. 3, pp. 143-184. Boca Raton, FL: CRC Press, 1984.
5. Dunn, J. A., and Blumberg, P. M. Specific binding of [20-3H)12-deoxyphor-bol 13-isobutyrate to phorbol ester receptor subclasses in mouse skin particulate preparations. Cancer Res., 43:4632-4637, 1983.
6. Blumberg, P. M. Protein kinase C as the receptor for the phorbol ester tumor promoters: Sixth Rhoads Memorial Award Lecture. Cancer Res., 48: 1-8, 1988.
7. Sekiguchi, K., Tsukuda, M., Ogita, K., Kikkawa, U., and Nishizuka, Y. Three distinct forms of rat brain protein kinase C: differential response to unsaturated fatty acids. Biochem. Biophys. Res. Commun., 145: 797-802, 1987.
8. Akita, Y., Ohno, S., Konno, Y., Yano, A., and Suzuki, K. Expression and properties of two distinct classes of the phorbol ester receptor family, four conventional protein kinase C types, and a novel protein kinase C. J. Biol. Chem., 265: 354-362, 1990.
9. Hergenhahn, M., Furstenberger, G., Opferkuch, H. J., Adolf, W., Mack, H., and Hecker, F. Biological assays for irritant tumor-initiating and -promoting activities. I. Kinetics of the irritant response in relation to the initiation-promoting activity of polyfunctional diterpenes representing tigliane and some daphnane types. J. Cancer Res. Clin. Oncol., 104:31-39, 1982.
10. Furstenberger, G., and Hecker, E. Zum Wirkungsmechanismus Cocarcino-gener Pflanzeninhaltsstoffe. Planta Med., 22: 241-266, 1972.
11. Slaga, T. J., Fischer, S. M., Nelson, K., and Gleason, G. L. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc. Natl. Acad. Sci. USA, 77:3659-3663, 1980.
12. Slaga, T. J. Overview of tumor promotion in animals. Environ. Health Perspect., 50:3-14, 1983.
13. Furstenberger, G., Berry, D. L., Sorg, B., and Marks, F. Skin tumor promotion by phorbol esters is a two-stage process. Proc. Natl. Acad. Sci. USA, 75:7722-7726, 1981.
14. Sako, T., Yuspa, S. H., Herald, C. H., Pettit, G. R., and Blumberg, P. M. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells. Cancer Res., 47: 5445-5450, 1987.
15. Gschwendt, M., Furstenberger, G., Rose-John, S., Rogers, M., Kittstein, W., Pettit, G., Herald, C. H., and Marks, F. Bryostatin 1, an activator of protein kinase C., mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro. Carcinogenesis (Lond.), 9: 555-562, 1988.
16. Hennings, H., Blumberg, P. M., Pettit, G. R., Herald, C. L., Shores, R., and Yuspa, S. H. Bryostatin I., an activator of protein kinase C., inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis (Lond.), 8: 1343-1346, 1987.
17. Schmidt, R., and Hecker, E. Simple phorbol esters as inhibitors of tumor promotion by TPA in mouse skin. In: E. Hecker, N. E. Fusenig, W. Kunz, F. Marks, and H. W. Thielmann (eds.), Cocarcinogenesis and Biological Effects of Tumor Promoters, pp. 57-63. New York: Raven Press, 1982.
18. Scribner, J. D., and Boutwell, R. K. Inflammation and tumor promotion: selective protein induction in mouse skin by tumor promoters. Eur. J. Cancer, 8:617-621, 1972.
19. Baird, W. M., and Boutwell, R. K. Tumor-promoting activity of phorbol and four diesters of phorbol in mouse skin. Cancer Res., 31: 1074-1079,1971.
20. Cashmore, A. R., Seelye, R. N., Cain, B. F., Mack, H., Schmidt, R., and Hecker, E. The structure of prostratin: a toxic tetracyclic diterpene ester from Pimelea prostrata. Tetrahedron Lett., 1737-1738,1976.
21. Zayed, S., Sorg, B., and Hecker, E. Structure activity relations of polyfunctional diterpenes of the tigliane type. VI. Planta Med., 34:65-69, 1984.
22. Sisskin, E. E., Gray, T., and Barrett, J. C. Correlation between sensitivity to tumor promotion and sustained epidermal hyperplasia of mice and rats treated with 12-0-tetradecanoylphorbol-13-acetate. Carcinogenesis (Lond.), 5:403-407, 1982.
23. O'Brien, T. G., Simsiman, R. C., and Boutwell, R. K. Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res., 55: 1662-1670,1975.
24. Lichti, U., and Gottesmann, M. M. Genetic evidence that a phorbol ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells. J. Cell. Physiol., 7/5:433-439, 1982.
25. Binder, R. L., Volpenhein, M. E., and Motz, A. A. Characterization of the induction of ornithine decarboxylase activity by benzoyl peroxide in SENCAR mouse epidermis. Carcinogenesis (Lond.), 10:2351-2357,1989.
26. Verma, A. K., Lowe, N. J., and Boutwell, R. K. Induction of mouse epidermal ornithine decarboxylase activity and DNA synthesis by ultraviolet light. Cancer Res., 39:1035-1040, 1979.
27. Irie, K., Hagiwara, N., Tokuda, H., and Koshimizu, K. Structure-activity studies of the indole alkaloid tumor promoter teleocidins. Carcinogenesis (Lond.), 8: 547-552, 1987.
28. Berry, D. L., Bracken, W. M., Fischer, S. M., Viaje, A., and Slaga, T. J. Metabolic conversion of 12-0-tetradecanoylphorbol-13-acetate in adult and newborn mouse liver microsomes. Cancer Res., 38:2301-2306,1978.
29. Whitman, M., and Cantley, L. Phosphoinositide metabolism and the control of cell proliferation. Biochim. Biophys. Acta, 948:327-344, 1988.
30. Rabin, M. S., Doherty, P. J., and Gottesman, M. M. The tumor promoter phorbol 12-myristate 13-acetate induces a program of altered gene expression similar to that induced by platelet-derived growth factor and transforming oncogenes. Proc. Natl. Acad. Sci. USA, 83:357-360,1986.
31. O'Brian, C. A., and Ward, N. E. Biology of the protein kinase C family. Cancer Metastasis Rev., 8:199-214,1989.
32. Lamph, W. W., Wamsley, P., Sassone-Corsi, P., and Verma, I. M. Induction of proto-oncogene 7LW/AP-1 by serum and TPA. Nature (Lond.), 334:629-631,1988.
33. Yamasaki, H. Modulation of cell differentiation by tumor promoters. In: T. J. Slaga (ed.), Mechanisms of Tumor Promotion, Vol. 4, pp. 1-26. Boca Raton, FL: CRC Press, 1984.
34. Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y. Isoquinolinesulfon-amides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry, 23:5036-5041,1984.
35. Hannun, Y. A., Loomis, C. R., Merrill, A. H., and Bell, R. M. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem., 261:12604-12609, 1986.
36. Tamaoki, K., Nomoto, H., Takahashi, I., Kato, Y., Morimoto, M., and Tomita, F. Staurosporine, a potent inhibitor of phospholipid/Ca2+ dependent protein kinase. Biochem. Biophys. Res. Commun., 135:397-402, 1986.
37. Nakano, H., Kobayashi, E., Takahashi, I., Tamaoki, T., Kuzuu, Y., and Iba, H. Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60. J. Antibiot. (Tokyo), 40: 706-708, 1987.
38. Watson, S. P., McNally, J., Shipman, L. J., and Godfrey, P. P. The action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol triphosphate by thrombin. Biochem. J., 249: 345-350,1988.
39. Fujita-Yamaguchi, Y., and Kathuria, S. Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-I receptor. Biochem. Biophys. Res. Commun., 157:955-962,1988.
40. Meyer, T., Regenass, U., Fabbro, D., Alteri, E., Rosel, J., Muller, M., Caravatti, G., and Matter, A. A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro antiproliferative as well as in vivo anti-tumor activity. Int. J. Cancer, 43:851-856, 1989.
41. Szallasi, A., Sharkey, N. A., and Blumberg, P. M. Structure/activity analysis of resiniferatoxin analogs. Phytother. Res., 5: 253-257, 1989.
42. Brooks, G., Evans, A. T., Aitken, A., and Evans, F. J. Tumour-promoting and hyperplastic effects of phorbol and daphnane esters in CD-I mouse skin and a synergistic effect of calcium ionophore with the nonpromoting activator of protein kinase C., sapintoxin A. Carcinogenesis (Lond.), 10: 283-288, 1989.
43. Fischer, S. M., Jasheway, D. W., Klann, R. C., Butler, A. P., Patrick, K. E., Baldwin, J. K., and Cameron, G. S. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C. Cancer Res., 49:6693-6699,1989.
44. Takigawa, M., Simsiman, R. C., and Boutwell, R. K. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-0-tetradecanoylphorbol-13-acetate in mouse epidermis. Cancer Res., 46: 106-112, 1986.
45. Young, J. M., Wagner, B. M., and Spires, D. M. Tachyphylaxis in 12-0-tetradecanoylphorbol-13-acetate-and arachidonic acid-induced ear edema. J. Invest. Dermatol., 80:48-52,1983.
46. O'Brien, T. G. The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res., 36:2644-2653, 1976.
47. Gilmour, S. K., Aglow, E., and O'Brien, T. G. Heterogeneity of ornithine decarboxylase expression in 12-0-tetradecanoylphorbol-13-acetate-treated mouse skin and in epidermal tumors. Carcinogenesis (Lond.), 7: 943-947, 1986.